SCHEMBL21912059

SCHEMBL21912059

C=C/C=C(/COc1nc(CC)c(CCCCc2cccc3ccccc23)c(N(CCCCC(=O)C=C)C[C@@H](C)CC#N)n1)N/C=C\C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21895575 0.73 — —
SCHEMBL21895564 0.72 — —
SCHEMBL21896266 0.72 — —
SCHEMBL21846436 0.72 KRAS (0.35) —
SCHEMBL21895630 0.72 — —
SCHEMBL21912088 0.71 — —
SCHEMBL22087305 0.71 — —
SCHEMBL21895594 0.70 — —
SCHEMBL21895625 0.70 — —
SCHEMBL21846281 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020055755-A1 COMBINATION THERAPIES Mirati Therapeutics, Inc. (US) 2020-03-19 — — WO disclosed
Send feedback